Journals / Turkish Journal of Obstetrics and Gynecology / 2021 / Cilt: 18 - Sayı: 3

Are women with polycystic ovary syndrome more vulnerable to COVID-19 infection?

Polikistik over sendromu olan kadınlar COVID-19 enfeksiyonuna daha mı hassaslar?

Pages
221–223
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In light of the metabolic and hormonal changes observed in women with PCOS, which make them more susceptible to severe COVID-19 infection, health care givers should provide special care and detailed counseling services.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Severe acute respiratory syndrome-coronavirus-2, the causative virus of Coronavirus disease-2019 (COVID-19), penetrates into the hosts’ tissues via binding of its spike protein to the angiotensin converting enzyme-2 (ACE-2) receptors after activation of the hosts’ protease enzymes.
📊
Key Findings & Data:The most prominent effect is observed when the virus binds to the ACE-2 receptors of the alveolar epithelium and endothelium.
💡
Conclusion & Impact:In light of the metabolic and hormonal changes observed in women with PCOS, which make them more susceptible to severe COVID-19 infection, health care givers should provide special care and detailed counseling services.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Severe acute respiratory syndrome-coronavirus-2, the causative virus of Coronavirus disease-2019 (COVID-19), penetrates into the hosts’ tissues via binding of its spike protein to the angiotensin converting enzyme-2 (ACE-2) receptors after activation of the hosts’ protease enzymes. The most prominent effect is observed when the virus binds to the ACE-2 receptors of the alveolar epithelium and endothelium. Testosterone exhibits an immunosuppressive effect, and androgens play a modulatory role on protease enzymes. It is known that various comorbidities, including obesity; pregnancy; diabetes mellitus (type 1 or type 2); hypertension; cancer; chronic kidney, liver, and lung diseases; cerebrovascular disease; heart conditions; human immunodeficiency virus infection; immunologic disease; and immune suppression; affect the severity of COVID-19 infection. Polycystic ovary syndrome (PCOS) affects 5-10% of reproductive aged-women. Hirsutism is observed in 70-80% of the patients, while increased testosterone levels are detected in more than 50% of the women with PCOS. This syndrome is also associated with hyperandrogenism, insulin resistance, increased renin-angiotensin system activity, diabetes, and metabolic syndrome in a remarkable number of cases. PCOS also manifests a chronic pro-inflammatory state. Hyperandrogenism through hyperinsulinemia causes adipocyte hypertrophy and dysfunction that result in increased secretion of pro-inflammatory adipokine, which culminates in the creation of a chronic inflammatory state. In light of the metabolic and hormonal changes observed in women with PCOS, which make them more susceptible to severe COVID-19 infection, health care givers should provide special care and detailed counseling services.

Özet

Şiddetli akut solunum sendromu-koronavirüs-2, spike proteinin konakçının proteaz enzimleri ile aktivasyonu sonrası anjiyotensin dönüştürücü enzim-2 (ACE-2) reseptörlerine bağlanır ve hücre içerisine girer. En önemli etkiler virüsün alveol epiteli ve endoteldeki ACE-2 reseptörlerine bağlanmasından sonra ortaya çıkar. Testosteronun immün sistemi baskılayıcı etkisi vardır ve androjenler proteaz enzimleri üzerinde düzenleyici rol oynar. Obezite, gebelik, diabet (tip 1 veya tip 2), hipertansiyon, kanser, kronik böbrek, karaciğer ve akciğer hastalıkları, serebrovasküler hastalıklar, kalp hastalıkları, insan bağışıklık yetmezliği virüsü enfeksiyonu, immünolojik hastalıklar, immünosüpresyon başta olmak üzere eşlik eden diğer hastalıklar Koronavirüs hastalığı-2019 (COVID-19) enfeksiyonunun ciddiyetini artırmaktadır. Polikistik over sendromu (PKOS) üreme çağındaki kadınların %5-10’unu etkiler, hastaların %70- 80’inde hirsutizm, %50’den fazlasında ise artmış testosteron düzeyleri saptanır. Bu sendrom hastaların önemli bir kısmında ayrıca hiperandrojenizm, insülin rezistansı, artmış renin-anjiyotensin sistemi aktivitesi, diyabet, metabolik sendrom ile ilişkilidir. PKOS ayrıca kronik pro-enflamatuvar bir durum gösterir. Hiperandrojenim hiperinsülinemi yoluyla adipositlerde hipertrofi ve fonksiyon bozukluğuna neden olarak pro-enflamatuvar adipokin sekresyonu ve kronik enflamatuvar bir duruma yol açar. PKOS’li kadınlarda onları ciddi COVID-19 enfeksiyonuna daha duyarlı hale getiren hormonal ve metabolik değişikliklerin ışığında sağlık hizmet sunucuları özel bir bakım ve ayrıntılı bir danışmanlık hizmeti sunmalıdır.

🔖

Cite This Article

Dilbaz, B. (2022). Are women with polycystic ovary syndrome more vulnerable to COVID-19 infection?. Turkish Journal of Obstetrics and Gynecology, Cilt: 18 - Sayı: 3, 221–223. https://ajindex.com/articles/612924

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Price LC, Mac Cabe C, Garfield B, Wort SJ. Thrombosis and COVID-19 pneumonia: the clot thickens! Eur Respir J 202056:2001608. doi: 10.1183/13993003.01608-2020 2. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020;94:e00127-20. doi: 10.1128/JVI.00127-20. 3. Kalidhindi RSR, Borkar NA, Ambhore NS, Pabelick CM, Prakash YS, Sathish V. Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19? Am J Physiol Lung Cell Mol Physiol 2020:319;L843-7. doi: 10.1152/ ajplung.00391.2020. 4. Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM. Is there an association between covıd-19 mortality and the reninangiotensin system? A call for epidemiologic ınvestigations. Clin Infect Dis 2020;28;71:870-4. 5. Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol 2020;20:442-7. 6. Kragholm K, Andersen MP, Gerds TA, Butt JH, Østergaard L, Polcwiartek C, et al. Association between male sex and outcomes of coronavirus disease 2019 (COVID-19)-a Danish Nationwide, register-based study, Clin Infect Dis 2020;, ciaa Ω924, doi:10.1093/cid/ciaa9249 7. Dudley JP, Lee NT. Disparities in age-specific morbidity and mortality from SARS-CoV-2 in China and the Republic of Korea. Clin Infect Dis 2020;15:863-5. 8. Guerson-Gil A, Palaiodimos L, Assa A, Karamanis D, Kokkinidis D, Chamorro-Pareja N, et al. Sex-specific impact of severe obesity in the outcomes of hospitalized patients with COVID-19: a large retrospective study from the Bronx, New York. Eur J Clin Microbiol Infect Dis 2021;40:1963-74. 9. Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med 2020;180:1345-55. 10. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020;369:m1966. doi: 10.1136/bmj.m1966. 11. Gagliardi MC, Tieri P, Ortona E, Ruggieri A. ACE2 expression and sex disparity in COVID-19. Cell Death Discov 2020;6:37. 12. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol 2016;16:626-38. 13. Bouman A